InvestorsHub Logo
Followers 68
Posts 823
Boards Moderated 0
Alias Born 03/19/2009

Re: Potse post# 6458

Friday, 11/11/2016 1:50:40 AM

Friday, November 11, 2016 1:50:40 AM

Post# of 28511
GSAC...finished accumulating position....

I accumulated shares of GSAC in the .003-.0035 range last week. GSAC acquired ownership of Mastix Medica about two years ago (and in the process gained exposure to the cannabis sector). GSAC is involved in the research/development, formulation, manufacturing, and marketing of over-the-counter healthcare products (gum, tablets, lozenges, mints, candies, etc.). The company has a patent-pending manufacturing process for incorporating hemp-oil into gums and tablets.



Finished accumulating a decent-sized position in GSAC by picking up more shares at .003 this week. Extremely high risk investment, but given the kinds of market caps that many stocks in the cannabis sector are attaining the risk/reward around that .003 level sure seems pretty enticing.

A couple items of interest that have occurred subsequent the above post.....

1) Last Friday (November 4) CEO Robert Estey made the following comment in response to a financial article about Axim Biotechnologies.....

I want to clarify one statement in this article with the real facts. In the article, you state “the founders of Axim are the inventors of CanChew”. This is an incorrect statement since my company Mastix Medica developed and owns the original formula for CanChew CBD gum. AXIM owns the trademark CanChew. We contract manufactured the original CanChew for Medical Marijuana, Inc. in 2013 and have applied for patents on our unique gum manufacturing process and formula compositions for functional gum. We do not infringe on the AXIM gum patent which is very limited in scope. Please contact me with any questions.



https://www.insiderfinancial.com/axim-biotechnologies-inc-otcmktsaxim-looks-well-supported-to-capitalize-on-further-upside-potential/118070/

2) Mastix issued a press release after today's market close. The company's first proprietary CBD product (MedCBDX) will officially launch next week. Snippets from the release......

MedCBDX Launched by Mastix LLC

HUNT VALLEY, Md., Nov. 10, 2016 /PRNewswire/ -- Mastix LLC has announced the launch of MedCBDX Chewing Gum, its first proprietary product. The leading developer and manufacturer of innovative functional food and dietary supplement products will formally launch the product at next week's Marijuana Business Conference and Expo in Las Vegas, NV from November 15th-18th, 2016 (Booth #521). The launch also includes a new website for MedCBDX products at www.medCBDX.com, where the product is available for purchase.......

......."We are thrilled to provide this unique CBD gum product to this growing market and we look forward to adding more products to the MedCBDX product in the future, like CBD lozenges," said Mastix CEO Bob Estey. "This product showcases our unique gum manufacturing ability to both customers and consumers. There are many benefits of using chewing gum and lozenges as a delivery method for functional products."



http://finance.yahoo.com/news/medcbdx-launched-mastix-llc-212000671.html;_ylt=AwrC1C50SiVYSywAgwKTmYlQ;_ylu=X3oDMTEyNmo2aW9rBGNvbG8DYmYxBHBvcwMyBHZ0aWQDVklEMDVfMQRzZWMDc2M-

http://medcbdx.com/

https://mobile.twitter.com/MedCbdx?p=s

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.